SHOT Show 2011: Barrett highlights capabilities
Barrett has used this year’s Shooting, Hunting and Outdoor Trade (SHOT) Show to highlight four new systems with military applications. The systems – the enhanced M107A1 model .50 caliber sniper rifle; the MRAD; the [M]240LW [lightweight] ‘concept’ machinegun; and REC7 assault rifle configuration in both 5.56mm NATO and 6.8mm SPC.
According to Kyle Lynch, director of sales and marketing for Barrett, many of the features incorporated in the M107A1 design reflect myriad lessons learned and close cooperation with the military user community. Major enhancements include a reduction in weapon weight (more than 6 lbs.) through the use of aluminum and
Already have an account? Log in
Want to keep reading this article?
More from Land Warfare
-
DSEI 2025: OpenWorks launches new system for on-the-move targeting
Vision Pace uses OpenWorks’ artificial intelligence (AI) classifiers and trackers to detect, track and identify multiple targets in land and naval applications for air defence.
-
DSEI 2025: Patria’s FAMOUS becomes TRACKX with production ready before end of 2027
The first two Technology Test Beds (TTBs) have been completed and put through a series of company trials including sand, snow, swamp, forest and tarmac.
-
DSEI 2025: General Dynamics firms up Ajax for potential British Army IFV requirement
Following the cancellation of the Lockheed Martin UK Warrior Capability Sustainment Programme (WCSP), the British Army will have a serious capability gap when the current Warrior infantry fighting vehicle (IFV) is soon phased out of service.
-
DSEI 2025: Trials completed for new version of Tridon air defence gun
Less than two years ago, Sweden’s BAE Systems Bofors announced it was developing a new 40mm short-range air defence system using internal research and development funding, calling it the Tridon Mk2.
-
DSEI 2025: Rheinmetall adds Lockheed Martin missile punch to Fuchs vehicle
The combination of the Rheinmetall platform with Lockheed Martin missiles is seen as the bringing together of mature systems to provide a capability in the medium term, but trials could be as long as 12 months away.